UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
1.
Building genetic medicine
: breast cancer, technology, and the comparative politics of health care
2007, 1, MIT Press Books, ISBN 0262162423, Volume 1, x, 271
Genetic screaning | United States | prevention & control | Social aspects | Breast Neoplasms | Genetic screening | Diagnostic use | Great Britain | Cross-Cultural Comparison | Delivery of Health Care | General Science | BRCA genes | Breast | Diagnosis | Ovarian Neoplasms | Cancer | Health Sciences | breast cancer; ovarian cancer; health care; Britain; United States
Book
Gynecologic oncology, ISSN 0090-8258, 11/2017, Volume 147, Issue 2, pp. 267 - 275
Ovarian carcinoma | Rucaparib | Somatic, germline BRCA mutation | PARP inhibitor | Oncology | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Neoplasms, Glandular and Epithelial - pathology | Humans | Middle Aged | Ovarian Neoplasms - pathology | Poly(ADP-ribose) Polymerase Inhibitors - adverse effects | Poly(ADP-ribose) Polymerase Inhibitors - therapeutic use | Ovarian Neoplasms - genetics | BRCA1 Protein - genetics | Neoplasms, Glandular and Epithelial - genetics | Indoles - adverse effects | Neoplasm Grading | Neoplasms, Glandular and Epithelial - drug therapy | Aged, 80 and over | Carcinoma, Ovarian Epithelial | Genes, BRCA2 | Germ-Line Mutation | Adult | Female | Indoles - therapeutic use | Aged | Genes, BRCA1 | Ovarian Neoplasms - drug therapy | BRCA2 Protein - genetics | Care and treatment | Genetic aspects | Carcinoma | Safety and security measures | Analysis | Cancer | Index Medicus
Journal Article
3.
Breast cancer gene research and medical practices
: transnational perspectives in the time of BRCA
2014, Genetics and society, ISBN 9780415824064, xxii, 225
BRCA genes | Breast | Genetic aspects | Tumor markers | Cancer | Anthropology | Cultural & Social | Sociology | Social Science | Health & Medical Anthropology | Anthropology - Soc Sci | New Genetics | Sociology of Science & Technology | Gender Studies | Medicine - Sociology | Bioethics | Genetics - Sociology | Medical Sociology | Sociology & Social Policy | Genetic screening
Book
Annals of oncology, ISSN 0923-7534, 01/2014, Volume 25, Issue 1, pp. 32 - 40
brca-like cancers | brca1/2 mutation | parp inhibitor | brca1/2 mutation-associated cancers | Parp inhibitor | Brca1/2 mutation | Brca1/2 mutation-associated cancers | Brca-like cancers | Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Tumors | BRCA1 Protein - genetics | Poly(ADP-ribose) Polymerases - metabolism | Animals | Neoplasms - genetics | Humans | Antineoplastic Agents - pharmacology | Clinical Trials as Topic | Mutation | Poly (ADP-Ribose) Polymerase-1 | Poly(ADP-ribose) Polymerase Inhibitors | BRCA2 Protein - genetics | Neoplasms - drug therapy | Index Medicus | brca1 | 2 mutation | Reviews | 2 mutation-associated cancers
Journal Article
5.
Full Text
Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations
Human mutation, ISSN 1059-7794, 2018, Volume 39, Issue 5, pp. 593 - 620
mutation | ethnicity | ovarian cancer | geography | breast cancer | BRCA1 | BRCA2 | Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Geography | BRCA1 Protein - genetics | Internationality | Humans | Databases, Genetic | Family | Mutation - genetics | BRCA2 Protein - genetics | Genetic aspects | BRCA mutations | Genetic screening | Singers | Ovarian cancer | BRCA2 protein | Mutation | Genotyping | BRCA1 protein | Minority & ethnic groups | Index Medicus | Life Sciences | Genetics | Human genetics | Medicin och hälsovetenskap
Journal Article
Molecular oncology, ISSN 1574-7891, 2011, Volume 5, Issue 4, pp. 387 - 393
Stalled replication fork | Homologous recombination | Poly(ADP-ribose) polymerase | Review | BRCA1 | Synthetic lethality | DNA double-strand breaks | BRCA2 | Cancer | Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | DNA Replication | DNA Breaks, Double-Stranded | Poly(ADP-ribose) Polymerase Inhibitors | DNA Breaks, Single-Stranded | BRCA1 Protein - genetics | Poly(ADP-ribose) Polymerases - metabolism | Animals | BRCA2 Protein - metabolism | BRCA1 Protein - antagonists & inhibitors | BRCA2 Protein - antagonists & inhibitors | Neoplasms - genetics | Recombination, Genetic | BRCA1 Protein - metabolism | DNA Repair | Models, Genetic | Neoplasms - pathology | BRCA2 Protein - genetics | DNA | Analysis | BRCA2 protein | BRCA1 protein | DNA damage | Genes | Lethality | Roles | DNA repair | Base excision repair | Intermediates | Replication forks | DNA biosynthesis | Proteins | Councils | Ribose | Deoxyribonucleic acid--DNA | Tumors | Index Medicus | Reviews
Journal Article
Nature cell biology, ISSN 1465-7392, 08/2018, Volume 20, Issue 8, pp. 954 - 965
Life Sciences & Biomedicine | Science & Technology | Cell Biology | Osteosarcoma - drug therapy | Mad2 Proteins - metabolism | Humans | Multiprotein Complexes | Ovarian Neoplasms - pathology | Bone Neoplasms - pathology | DNA Breaks, Double-Stranded | Bone Neoplasms - metabolism | Breast Neoplasms - metabolism | Dose-Response Relationship, Drug | Ovarian Neoplasms - genetics | Telomere-Binding Proteins - genetics | DNA End-Joining Repair | HEK293 Cells | Female | Bone Neoplasms - genetics | Ovarian Neoplasms - metabolism | Bone Neoplasms - drug therapy | BRCA1 Protein - deficiency | Telomere-Binding Proteins - metabolism | Ovarian Neoplasms - drug therapy | Osteosarcoma - metabolism | DNA-Binding Proteins | Tumor Suppressor p53-Binding Protein 1 - metabolism | Recombinational DNA Repair | Tumor Suppressor p53-Binding Protein 1 - genetics | Cisplatin - pharmacology | Breast Neoplasms - drug therapy | Proteins - genetics | Xenograft Model Antitumor Assays | BRCA1 Protein - genetics | Poly(ADP-ribose) Polymerase Inhibitors - pharmacology | Drug Resistance, Neoplasm - genetics | Animals | Breast Neoplasms - genetics | Proteins - metabolism | Breast Neoplasms - pathology | Mad2 Proteins - genetics | Cell Line, Tumor | Mice | Osteosarcoma - genetics | Cell Cycle Proteins | Osteosarcoma - pathology | Care and treatment | DNA | Cancer cells | Breast cancer | Genetic aspects | Research | Gene expression | Single-stranded DNA | DNA damage | Homologous recombination | Poly(ADP-ribose) | Homology | Genomes | Inactivation | Proteins | Ribose | Null cells | Deoxyribonucleic acid--DNA | BRCA2 protein | CRISPR | Deactivation | BRCA1 protein | Poly(ADP-ribose) polymerase | Adenosine diphosphate | Oligosaccharides | Double-strand break repair | Screens | Cisplatin | Inhibitors | Prostate | Viability | Tumors | Index Medicus | Telomere-Binding Proteins / metabolism | Osteosarcoma / genetics | Telomere-Binding Proteins / genetics | BRCA1 Protein / genetics | Cellular Biology | Genetics | Proteins / genetics | Osteosarcoma / drug therapy | Ovarian Neoplasms / genetics | Mad2 Proteins / genetics | Proteins / metabolism | Breast Neoplasms / drug therapy | Breast Neoplasms / metabolism | Tumor Suppressor p53-Binding Protein 1 / genetics | BRCA1 Protein / deficiency | Ovarian Neoplasms / metabolism | Mad2 Proteins / metabolism | Breast Neoplasms / pathology | Bone Neoplasms / genetics | Ovarian Neoplasms / pathology | Bone Neoplasms / pathology | Life Sciences | Bone Neoplasms / drug therapy | Ovarian Neoplasms / drug therapy | Osteosarcoma / metabolism | Biochemistry, Molecular Biology | Breast Neoplasms / genetics | Drug Resistance, Neoplasm / genetics | Osteosarcoma / pathology | Bone Neoplasms / metabolism | Poly(ADP-ribose) Polymerase Inhibitors / pharmacology | Cisplatin / pharmacology | Molecular biology | Tumor Suppressor p53-Binding Protein 1 / metabolism | Cancer
Journal Article